We’re untangling an emerging phenomenon: that a high valuation can sometimes be a detriment, rather than an asset, when it comes to recruiting key AI talent.
Xaira, Anthos, CureVac & more—Chutes & Ladders fiercebiotech.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fiercebiotech.com Daily Mail and Mail on Sunday newspapers.